Lexaria Bioscience Corp (LEXX)

$0.93 +0.02 (2.04%)
Market Cap 20.23M
Revenue (ttm) 460,000.00
Net Income (ttm) -5.80M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -1,260.87%
Debt to Equity Ratio 0.00
Volume 118,300
Avg Vol 669,182
Day's Range N/A - N/A
Shares Out 22.23M
Stochastic %K 80%
Beta 0.81
Analysts Strong Sell
Price Target $5.33

Company Profile

Lexaria Bioscience Corp. operates as a biotechnology company. It offers its patented drug delivery-enabling platform technology, DehydraTECH, which combines active pharmaceutical ingredients (APIs) with specific long-chain fatty acid-rich triglyceride oils and carrier compounds that improve the way they enter the bloodstream, increasing their effectiveness and allowing for lower overall dosing for improved tolerability while promoting healthier oral ingestion methods. The company's DehydraTECH i...

Industry: Biotechnology
Sector: Healthcare
Phone: 250 765 6424
Address:
740 McCurdy Road, Suite 100, Kelowna, Canada
hovelaque
hovelaque Oct. 25 at 4:50 PM
$LEXX before last 2.76MM offer company placed another 2.76MM total new shares 5.5MM over previous 20MM is like 28% dilution. SP was 1.5$ so now is .95 pure maths. Lexx has now more than 7MM in cash. and a MC of 20MM. no debt. MC looks cheap IMHO. IF NR hit with good news...I think we can see +1.5$ and IF joint venture or licencing is announced so +2$ should be. GLTA. Hope to make some money being long.
0 · Reply
wa7ermelon
wa7ermelon Oct. 24 at 10:51 PM
$LEXX the potential here
0 · Reply
Makingmillions192
Makingmillions192 Oct. 24 at 9:26 PM
$LEXX Go Jays Go!! Have a great weekend gents
0 · Reply
Turbofueled
Turbofueled Oct. 24 at 7:48 PM
$LEXX
0 · Reply
Zipcash
Zipcash Oct. 24 at 7:19 PM
$LEXX
0 · Reply
Makingmillions192
Makingmillions192 Oct. 24 at 5:34 PM
$LEXX Fuck I’ve never seen someone try this hard to hold down the price lol. They’re gonna get smoked 😉 
0 · Reply
Turbofueled
Turbofueled Oct. 24 at 5:15 PM
$LEXX This is going to go Crazy!!!
0 · Reply
Turbofueled
Turbofueled Oct. 24 at 5:14 PM
$LEXX Rocking! GLP-1 $NVO Coming Soon $LEXX https://abcnews.go.com/GMA/Wellness/video/glp-1-drugs-good-heart-126789234
0 · Reply
Shubeedoo
Shubeedoo Oct. 24 at 4:31 PM
$LEXX So Long, it's one week from November. You think we hear on the 1b this year? With the price down here, sure to see tax selling, if not already started.
1 · Reply
LongLEXX
LongLEXX Oct. 24 at 3:49 PM
$LEXX Novo's oral GLP-1 Rybelsus approved by FDA for lowering the risk of major cardiovascular complications. https://www.cnbc.com/2025/10/21/healthy-returns-a-key-step-forward-for-novo-nordisks-glp-1-pill.html Bodes well for LEXX to have so many potential applications in the GLP-1 space. At least a dozen pharma companies vying for position here. Not if but when!
0 · Reply
Latest News on LEXX
Lexaria Bioscience Corp. Provides Strategic Update

Oct 9, 2025, 9:20 AM EDT - 16 days ago

Lexaria Bioscience Corp. Provides Strategic Update

Lexaria Bioscience Corp. Announces Closing of $4.0 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

Sep 29, 2025, 4:30 PM EDT - 26 days ago

Lexaria Bioscience Corp. Announces Closing of $4.0 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

Lexaria Bioscience Corp. Announces $4.0 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

Sep 26, 2025, 8:10 AM EDT - 4 weeks ago

Lexaria Bioscience Corp. Announces $4.0 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

Lexaria's Technology Supports Higher Levels of the GLP-1 Drug Semaglutide in Brain

Sep 19, 2025, 11:20 AM EDT - 5 weeks ago

Lexaria's Technology Supports Higher Levels of the GLP-1 Drug Semaglutide in Brain

Lexaria Attending the 27th Annual H.C. Wainwright Global Investment Conference

Aug 27, 2025, 9:20 AM EDT - 2 months ago

Lexaria Attending the 27th Annual H.C. Wainwright Global Investment Conference

Lexaria's Phase 1b GLP-1 Study Achieves Important "Last Patient Last Visit" Milestone

Aug 14, 2025, 9:20 AM EDT - 2 months ago

Lexaria's Phase 1b GLP-1 Study Achieves Important "Last Patient Last Visit" Milestone

GLP-1 "Arms Race" Broadens to Include Dozens of Companies

Aug 6, 2025, 9:20 AM EDT - 2 months ago

GLP-1 "Arms Race" Broadens to Include Dozens of Companies

Lexaria Provides Positive Interim Results on Partial 8-week Data From Phase 1b, GLP-1-H24-4 Study

Jul 28, 2025, 9:25 AM EDT - 3 months ago

Lexaria Provides Positive Interim Results on Partial 8-week Data From Phase 1b, GLP-1-H24-4 Study

Lexaria Provides Positive Interim Results on Partial 8-week Data from Phase 1b, GLP-1-H24-4 Study

Jul 28, 2025, 9:25 AM EDT - 3 months ago

Lexaria Provides Positive Interim Results on Partial 8-week Data from Phase 1b, GLP-1-H24-4 Study

Lexaria's DehydraTECH Technology Has the Potential to Unlock Accelerated Revenue Growth in the GLP-1-Industry

Jul 23, 2025, 9:25 AM EDT - 3 months ago

Lexaria's DehydraTECH Technology Has the Potential to Unlock Accelerated Revenue Growth in the GLP-1-Industry

Lexaria Reaches Patent Milestone - 50 Patents Now Granted Worldwide

Jun 23, 2025, 9:15 AM EDT - 4 months ago

Lexaria Reaches Patent Milestone - 50 Patents Now Granted Worldwide

Lexaria's DehydraTECH-Liraglutide Human GLP-1 Clinical Study Supports Pathway to Potential FDA Registration as an Orally-Delivered Capsule

Jun 11, 2025, 9:05 AM EDT - 4 months ago

Lexaria's DehydraTECH-Liraglutide Human GLP-1 Clinical Study Supports Pathway to Potential FDA Registration as an Orally-Delivered Capsule

Lexaria Attending BIO International Convention

Jun 5, 2025, 9:20 AM EDT - 5 months ago

Lexaria Attending BIO International Convention

Lexaria Provides Update on Material Transfer Agreement with Pharmaceutical Company

May 12, 2025, 9:00 AM EDT - 5 months ago

Lexaria Provides Update on Material Transfer Agreement with Pharmaceutical Company

Lexaria Announces Closing of $2 Million Registered Direct Offering of Common Stock

Apr 28, 2025, 4:15 PM EDT - 6 months ago

Lexaria Announces Closing of $2 Million Registered Direct Offering of Common Stock

Lexaria Announces $2 Million Registered Direct Offering of Common Stock

Apr 25, 2025, 8:00 AM EDT - 6 months ago

Lexaria Announces $2 Million Registered Direct Offering of Common Stock

Recent GLP-1-Industry Developments Highlight the Promise of Lexaria Bioscience's Technology

Apr 23, 2025, 9:10 AM EDT - 6 months ago

Recent GLP-1-Industry Developments Highlight the Promise of Lexaria Bioscience's Technology

Lexaria Updates its Ongoing Human Study GLP-1-H24-4

Apr 3, 2025, 9:10 AM EDT - 7 months ago

Lexaria Updates its Ongoing Human Study GLP-1-H24-4

Lexaria's Human GLP-1 Study #5 Begins Dosing

Apr 2, 2025, 9:05 AM EDT - 7 months ago

Lexaria's Human GLP-1 Study #5 Begins Dosing

Lexarias' DehydraTECH-tirzepatide Oral Capsules Achieve Comparable Levels in Bloodstream as Eli Lilly's Injectable Zepbound

Mar 18, 2025, 9:15 AM EDT - 7 months ago

Lexarias' DehydraTECH-tirzepatide Oral Capsules Achieve Comparable Levels in Bloodstream as Eli Lilly's Injectable Zepbound

Lexaria's DehydraTECH-tirzepatide Oral Capsules Achieve Comparable Levels in Bloodstream as Eli Lilly's Injectable Zepbound(R)

Mar 18, 2025, 9:15 AM EDT - 7 months ago

Lexaria's DehydraTECH-tirzepatide Oral Capsules Achieve Comparable Levels in Bloodstream as Eli Lilly's Injectable Zepbound(R)

The Global Revolution in Healthcare Driven by GLP-1 Drugs and the role of Lexaria Bioscience

Feb 27, 2025, 8:00 AM EST - 8 months ago

The Global Revolution in Healthcare Driven by GLP-1 Drugs and the role of Lexaria Bioscience

Ethics Board Approval Received for DehydraTECH-tirzepatide GLP-1 Study-Arm

Feb 24, 2025, 8:00 AM EST - 8 months ago

Ethics Board Approval Received for DehydraTECH-tirzepatide GLP-1 Study-Arm

Lexaria's Strategic Business Pursuit of DehydraTECH-Liraglutide

Feb 20, 2025, 8:00 AM EST - 8 months ago

Lexaria's Strategic Business Pursuit of DehydraTECH-Liraglutide

Lexaria Granted Two New DehydraTECH Patents for Treatment of Epilepsy

Feb 11, 2025, 8:00 AM EST - 9 months ago

Lexaria Granted Two New DehydraTECH Patents for Treatment of Epilepsy

Lexaria Biodistribution Study For DehydraTECH GLP-1 is Underway

Feb 6, 2025, 9:40 AM EST - 9 months ago

Lexaria Biodistribution Study For DehydraTECH GLP-1 is Underway

Lexaria Releases Annual Letter from the CEO

Jan 30, 2025, 9:15 AM EST - 9 months ago

Lexaria Releases Annual Letter from the CEO

Lexaria's Human GLP-1 Study #5 Receives Independent Review Board Approval

Jan 15, 2025, 9:20 AM EST - 10 months ago

Lexaria's Human GLP-1 Study #5 Receives Independent Review Board Approval

Lexaria's Oral DehydraTECH-Tirzepatide Reduces Side Effects by Half with Comparable Efficacy Versus Eli Lilly's Injectable GLP-1/GIP Drug Zepbound(R)

Jan 14, 2025, 9:10 AM EST - 10 months ago

Lexaria's Oral DehydraTECH-Tirzepatide Reduces Side Effects by Half with Comparable Efficacy Versus Eli Lilly's Injectable GLP-1/GIP Drug Zepbound(R)

Lexaria's Registered GLP-1 Study #4 Begins Dosing

Dec 19, 2024, 9:05 AM EST - 11 months ago

Lexaria's Registered GLP-1 Study #4 Begins Dosing

Lexaria Forms New Scientific Advisory Board

Dec 18, 2024, 9:25 AM EST - 11 months ago

Lexaria Forms New Scientific Advisory Board

Esteemed Harvard Medical School Professor Dr. Michael Gibson Appointed Chief Medical Advisor at Lexaria Bioscience

Dec 17, 2024, 9:10 AM EST - 11 months ago

Esteemed Harvard Medical School Professor Dr. Michael Gibson Appointed Chief Medical Advisor at Lexaria Bioscience

Liraglutide Processed with DehydraTECH to be Studied in Human GLP-1 Study #5

Dec 9, 2024, 9:10 AM EST - 11 months ago

Liraglutide Processed with DehydraTECH to be Studied in Human GLP-1 Study #5

Revolutionizing Healthcare: Lexaria Highlights Expanding Therapeutic Benefits of GLP-1 Drugs

Nov 26, 2024, 9:20 AM EST - 11 months ago

Revolutionizing Healthcare: Lexaria Highlights Expanding Therapeutic Benefits of GLP-1 Drugs

Lexaria's GLP-1 Human Pilot Study #3 Completes Dosing as Scheduled

Nov 25, 2024, 9:00 AM EST - 11 months ago

Lexaria's GLP-1 Human Pilot Study #3 Completes Dosing as Scheduled

ALL Study Groups using DehydraTECH Processing Outperform Rybelsus(R) in Body Weight Control in Lexaria's 12-Week GLP-1, Diabetes Animal Study

Nov 20, 2024, 9:05 AM EST - 1 year ago

ALL Study Groups using DehydraTECH Processing Outperform Rybelsus(R) in Body Weight Control in Lexaria's 12-Week GLP-1, Diabetes Animal Study

Lexaria Signs Contract For New DehydraTECH GLP-1 Biodistribution Study

Nov 14, 2024, 9:10 AM EST - 1 year ago

Lexaria Signs Contract For New DehydraTECH GLP-1 Biodistribution Study

Ethics Board Approval Granted for Lexaria's 12-Week Phase 1b DehydraTECH GLP-1 Study in Diabetes and Weight Loss

Nov 13, 2024, 9:20 AM EST - 1 year ago

Ethics Board Approval Granted for Lexaria's 12-Week Phase 1b DehydraTECH GLP-1 Study in Diabetes and Weight Loss

Lexaria Updates Fast-Moving GLP-1 'Arm's Race' Developments

Nov 7, 2024, 9:15 AM EST - 1 year ago

Lexaria Updates Fast-Moving GLP-1 'Arm's Race' Developments

Positive Partial 12-Week Blood Sugar Results from Lexaria's GLP-1 Diabetes Animal Study

Oct 24, 2024, 9:10 AM EDT - 1 year ago

Positive Partial 12-Week Blood Sugar Results from Lexaria's GLP-1 Diabetes Animal Study

Positive Partial 12-Week Body Weight Results from Lexaria's GLP-1 Diabetes Animal Study

Oct 22, 2024, 9:20 AM EDT - 1 year ago

Positive Partial 12-Week Body Weight Results from Lexaria's GLP-1 Diabetes Animal Study

Lexaria Announces Closing of $5 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules

Oct 16, 2024, 4:00 PM EDT - 1 year ago

Lexaria Announces Closing of $5 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules

Lexaria Announces $5 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules

Oct 15, 2024, 8:25 AM EDT - 1 year ago

Lexaria Announces $5 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules

Lexaria's GLP-1 Human Pilot Study #3 Begins Dosing

Oct 9, 2024, 9:05 AM EDT - 1 year ago

Lexaria's GLP-1 Human Pilot Study #3 Begins Dosing

Lexaria Updates Current GLP-1 Market

Oct 8, 2024, 9:20 AM EDT - 1 year ago

Lexaria Updates Current GLP-1 Market

Lexaria Appoints Michael Shankman as Chief Financial Officer

Oct 1, 2024, 9:25 AM EDT - 1 year ago

Lexaria Appoints Michael Shankman as Chief Financial Officer

Lexaria Receives Independent Review Board Approval to Begin Human Pilot Study #3

Sep 27, 2024, 9:20 AM EDT - 1 year ago

Lexaria Receives Independent Review Board Approval to Begin Human Pilot Study #3

Lexaria Releases Strategic Letter from the Outgoing CEO

Sep 5, 2024, 10:00 AM EDT - 1 year ago

Lexaria Releases Strategic Letter from the Outgoing CEO

Lexaria Welcomes Industry Veteran as New CEO

Sep 5, 2024, 9:00 AM EDT - 1 year ago

Lexaria Welcomes Industry Veteran as New CEO

Lexaria Enters a Material Transfer Agreement for DehydraTECH Research

Sep 3, 2024, 8:30 AM EDT - 1 year ago

Lexaria Enters a Material Transfer Agreement for DehydraTECH Research

hovelaque
hovelaque Oct. 25 at 4:50 PM
$LEXX before last 2.76MM offer company placed another 2.76MM total new shares 5.5MM over previous 20MM is like 28% dilution. SP was 1.5$ so now is .95 pure maths. Lexx has now more than 7MM in cash. and a MC of 20MM. no debt. MC looks cheap IMHO. IF NR hit with good news...I think we can see +1.5$ and IF joint venture or licencing is announced so +2$ should be. GLTA. Hope to make some money being long.
0 · Reply
wa7ermelon
wa7ermelon Oct. 24 at 10:51 PM
$LEXX the potential here
0 · Reply
Makingmillions192
Makingmillions192 Oct. 24 at 9:26 PM
$LEXX Go Jays Go!! Have a great weekend gents
0 · Reply
Turbofueled
Turbofueled Oct. 24 at 7:48 PM
$LEXX
0 · Reply
Zipcash
Zipcash Oct. 24 at 7:19 PM
$LEXX
0 · Reply
Makingmillions192
Makingmillions192 Oct. 24 at 5:34 PM
$LEXX Fuck I’ve never seen someone try this hard to hold down the price lol. They’re gonna get smoked 😉 
0 · Reply
Turbofueled
Turbofueled Oct. 24 at 5:15 PM
$LEXX This is going to go Crazy!!!
0 · Reply
Turbofueled
Turbofueled Oct. 24 at 5:14 PM
$LEXX Rocking! GLP-1 $NVO Coming Soon $LEXX https://abcnews.go.com/GMA/Wellness/video/glp-1-drugs-good-heart-126789234
0 · Reply
Shubeedoo
Shubeedoo Oct. 24 at 4:31 PM
$LEXX So Long, it's one week from November. You think we hear on the 1b this year? With the price down here, sure to see tax selling, if not already started.
1 · Reply
LongLEXX
LongLEXX Oct. 24 at 3:49 PM
$LEXX Novo's oral GLP-1 Rybelsus approved by FDA for lowering the risk of major cardiovascular complications. https://www.cnbc.com/2025/10/21/healthy-returns-a-key-step-forward-for-novo-nordisks-glp-1-pill.html Bodes well for LEXX to have so many potential applications in the GLP-1 space. At least a dozen pharma companies vying for position here. Not if but when!
0 · Reply
Shubeedoo
Shubeedoo Oct. 24 at 3:18 PM
$LEXX Sellers done? Looking forward to another run, just not sure where the cap is. With no 1b, MTA, global partner, lender news or names, guess we just have to let the players/manipulators or whatever you want to call them run the show for now. Until we have solid positive news that induces long term major players to buy and hold, we are at the mercy of those who know how to make money on speculation. Because speculation is all we definitely have right now.
0 · Reply
Makingmillions192
Makingmillions192 Oct. 24 at 3:09 PM
$LEXX $LEXX Weekly chart - RSI/MACD suggesting a massive trend reversal is in play here. Great to see 💰 Going to be a really fun fall/ winter I suspect 🚀
0 · Reply
the_real_Joker
the_real_Joker Oct. 24 at 2:10 PM
$HOWL Yea, I missed selling that thing too; I could have bought it back now. However, I'm still well in the black. But it takes more patience than $IXHL and $LEXX in my long BIO Portfolio. It'll be fine. I still believe in the products of these. ... back in in $MIRA & $PSTV...
1 · Reply
Makingmillions192
Makingmillions192 Oct. 24 at 1:46 PM
$LEXX Technicals look primed for a bump up here
0 · Reply
Turbofueled
Turbofueled Oct. 24 at 1:26 PM
$LEXX shorts 280k
1 · Reply
nlstbro
nlstbro Oct. 24 at 1:15 PM
$LEXX
0 · Reply
Makingmillions192
Makingmillions192 Oct. 24 at 12:41 PM
$LEXX Feels like we take back $1 today - lining up another 10k to buy
1 · Reply
The_Wealth_Maker
The_Wealth_Maker Oct. 24 at 12:30 PM
$LEXX Investing in Lexaria since 2019, back when it was a Canadian ticker.
0 · Reply
Turbofueled
Turbofueled Oct. 24 at 11:31 AM
$LEXX
0 · Reply
wa7ermelon
wa7ermelon Oct. 24 at 7:21 AM
$LEXX - This is the one biotech everyone will chase at $10+ after pretending they “knew” all along. Facts: 🚀 First real solution to GLP-1 nausea 🚀 Oral delivery WITHOUT gut damage 🚀 Faster uptake 🚀 Massive human data readout IMMINENT 🚀 Multiple pharma already circling behind the scenes 🚀 Micro float – explosive setup This isn’t a meme stock. This is a platform technology worth billions — still sitting under $1 because the market is brain-dead short term. They delay. I accumulate. They doubt. I prepare. When this detonates… it won’t be a gentle climb. It’ll be limit up violence. WINTER OF GLP-1 = $LEXX SEASON ❄️🔥 #tarrifs #Biotech #GLP1 #Trump #OralSemaglutide #Pharma #LoadZone #SmallCaps #TenBagger #StockMarket
0 · Reply
Shubeedoo
Shubeedoo Oct. 23 at 7:48 PM
$LEXX stage is set. Just like a couple of times before, street has been clean and we should be seeing some nice upward movement very soon. Pattern is very consistent and easy to trade a few, if that’s your style. 
0 · Reply
Makingmillions192
Makingmillions192 Oct. 23 at 6:57 PM
$LEXX
0 · Reply